There is no clinical trial data comparing split versus single weekly dosing for semaglutide specifically, so this falls into the category of community-derived optimization
This coverage has been available since the FDA approved the cardiovascular indication in March 2024
Formulated with Snail Secretion Filtrate, Coconut Oil, Kojic Acid, Glycerin, Lactic Acid, Carica Papaya Fruit Extract, Arbutin, Paeonia Suffruticosa Root Extract, Scutellaria Baicalensis Root Extract and Glutathione
Nature 447 (7146), 869874
The cardioprotective effects operate through the CD36 receptor, which is broadly expressed throughout the cardiovascular system
Thats not cheap anymore